Search

CNA understands the unique risks associated with life sciences innovation. We offer a wide range of insurance solutions for life sciences organizations.

Over the past five years, Canada’s life sciences industry has flourished. In 2021, Ontario alone recorded $846.8 million of venture capital investments in life sciences.

Bringing life-changing drugs and medical devices to market involves a number of specialist life science companies working together to research, design, trial, manufacture and distribute new products.

CNA’s Ruth Stewart and Michael Brennan featured in IB Talk, the Insurance Business Canada podcast, discussing the current state of the life science market, what the future looks like for clinical trials across Canada, and how risk control can help reduce the risk of claims in this sector.

Middle Market | Canada The field of life sciences is at the forefront of a rapidly evolving healthcare landscape, fueled by innovation and the drive to improve the human experience. But pricing…

Over the past 40 years, CNA has built a reputation of a trusted leader in the life science industry. Our success reflects our heritage of continuity and our dedication to meeting the needs of a…

Healthcare | Canada For more than 30 years, CNA has been a market-leading provider of insurance solutions to life sciences companies, offering proprietary coverage strengthened by a deep…

For more than 25 years, CNA has been a market-leading provider of insurance solutions to life sciences companies. We evaluate risks in the following areas: • Biotechnology –The applied research,…

Canada | Life Sciences CNA’s Life Sciences Products – Work Hazard Liability and Professional Liability Insurance Policy is designed to address the unique liability concerns facing clients and…

Clinical research organizations (CROs) CROs support drug and device manufacturers on their road to discovery and eventual approval of future drugs by alleviating the burdens placed on the R&D…